Chang et al. evaluated the effect of epoetin alfa (40,000 units administered subcutaneously every week) and standard-of-care therapy on quality of life (QOL), transfusion requirements, and ...
In a randomized, controlled, open-label, 12-week trial, Chang et al. [6] evaluated the effect of epoetin alfa (40,000 units administered subcutaneously every week) or SOC therapy on QOL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback